NCT04288791

Brief Summary

This study is conducted to evaluate the clinical performance of class I reinforced glass ionomer restorations (Zirconomer Improved and Equia Forte Fil)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2018

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2019

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

February 26, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 28, 2020

Completed
Last Updated

March 17, 2020

Status Verified

March 1, 2020

Enrollment Period

2 months

First QC Date

February 26, 2020

Last Update Submit

March 15, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinical Performance of the restoration

    Success Rate

    6 months

Study Arms (2)

Equia Forte Fil

EXPERIMENTAL
Other: Equia Forte FilOther: Zirconomer Improved

Zirconomer Improved

EXPERIMENTAL
Other: Equia Forte FilOther: Zirconomer Improved

Interventions

Glass hybrid innovation achieved through the introduction of ultrafine, highly reactive glass particles dispersed with conventional GI. The restoration is coated with Equia Forte coat which incorporates multi-functional monomer producing a tougher resin matrix. This system is designed as alternative of amalgam in posterior teeth.

Equia Forte FilZirconomer Improved

Zirconia reinforced GI, Glass Polyalkenoate restoration; it is designed to exhibit high strength where the glass component of this GI undergoes finely controlled micronization to achieve optimum particle size and characteristics .

Equia Forte FilZirconomer Improved

Eligibility Criteria

Age20 Years - 47 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Normal occlusal relation with normal dentition.
  • Absence of pain from the tooth to be restored.
  • Absence of any active periodontal and pulpal diseases from the tooth to be restored.
  • Medium-sized (buccolingually and mesio-distally) occlusal carious lesions extending into dentin.

You may not qualify if:

  • Patients with a history of tooth sensitivity.
  • Patients with bruxism.
  • Defective restorations adjacent or opposing to the tooth.
  • Abutment teeth used for fixed or removable prosthesis.
  • Patients who refused to sign the consent form.
  • Inability to return to recall appointments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Al-Azhar University, Faculty of Dentistry For Girls

Cairo, Egypt

Location

MeSH Terms

Conditions

Dental Caries

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

February 26, 2020

First Posted

February 28, 2020

Study Start

June 1, 2018

Primary Completion

August 1, 2018

Study Completion

February 1, 2019

Last Updated

March 17, 2020

Record last verified: 2020-03

Locations